175 results on '"Krishnatry, R."'
Search Results
2. High-dose salvage re-irradiation in recurrent/progressive adult diffuse gliomas: development of a novel prognostic scoring system
3. Impact of Adjuvant Treatment in pN3 Penile Cancer
4. Radiotherapy for Post-Chemotherapy Residual Mass in Advanced Seminoma: A Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Risk-adapted Approach
5. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
6. Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate Cancer
7. Prospective Longitudinal Assessment of Quality of Life and Activities of Daily Living as Patient-Reported Outcome Measures in Recurrent/Progressive Glioma Treated with High-dose Salvage Re-irradiation
8. Dose Escalation Using Magnetic Resonance Guided High-Dose-Rate Endorectal Brachytherapy to Enhance Clinical Response after Neoadjuvant Radiotherapy in Rectal Adenocarcinoma
9. Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose Escalation
10. An Audit for Radiotherapy Planning and Treatment Errors From a Low–Middle-Income Country Centre
11. PO-1395 SIB-IMRT boost during SCRT and chemotherapy for locally advanced rectal cancer
12. PO-2340 The emerging role of radiation therapists in contouring organs at risk for rectal cancer.
13. Early Results of Extreme Hypofractionation Using Stereotactic Body Radiation Therapy for High-risk, Very High-risk and Node-positive Prostate Cancer
14. Reduction of Tumor Length by >50%, Post Neoadjuvant Chemoradiation as a Predictor for Complete Response and Organ Preservation in Rectal Cancer
15. P-255 Outcome of local radiation therapy in oligo-recurrent biliary tract cancers
16. P-201 Using SBRT in treating oligorecurrences of carcinoma of stomach
17. PO-1282 Local control still a challenge in post-SBRT advanced Pancreatic cancer - A single institute series
18. PD-0852 Recommendations and clinical validation of inguinal CTV delineation in penile cancer
19. OC-0613: Prostate Only or Pelvic Radiotherapy in High Risk Prostate Cancer: Outcomes of a Randomised Trial
20. PO-139: Cushing’s disease outcomes with conventional fractionated modern stereotactic conformal or IM-IGRT
21. Combination of urinary symptoms & cytology can decrease the need of cystoscopies at regular follow-up assessments for post triple modality bladder preservation treatment in MIBC
22. Optimizing Immobilization and IGRT schedule for decreasing PTV margins for supine Cranio-spinal irradiation
23. Pattern of care in high-grade gliomas after recurrence
24. Institutional experience of re-RT in Diffuse Intrinsic Pontine Glioma
25. Multidisciplinary brain metastasis clinic: Is it effective and worthwhile?
26. PV-0629 Late toxicity and PROMs in pelvic or prostate RT in high risk prostate cancer: A randomized trial.
27. PO-0863 Adaptive radiotherapy for carcinoma of the urinary bladder: Long term outcomes with dose escalation
28. EP-1235 Response to re-RT helps deciding dose and predicts survival in Diffuse Intrinsic Pontine Glioma
29. EP-1586 FDG PET-CT based risk-adapted radiotherapy for post-chemotherapy residual mass in advanced seminoma
30. Survey on Adaptive Radiotherapy Practice
31. Adaptive radiotherapy for carcinoma of the urinary bladder: Long term outcomes with dose escalation
32. P05.13 Long term clinical outcomes with helical tomotherapy based image guided intensity modulated radiotherapy for benign and low grade brain tumours
33. Factors predicting 'time to distant metastasis' in radically treated head and neck cancer
34. PO-0712: Radiomics to predict medulloblastomas molecular subgroups: prospective blinded data of 111 patients
35. Ga-68 PSMA PETCT response to androgen deprivation therapy in patients with prostate cancer
36. 57P - Multidisciplinary brain metastasis clinic: Is it effective and worthwhile?
37. 59P - Pattern of care in high-grade gliomas after recurrence
38. P143 - Combination of urinary symptoms & cytology can decrease the need of cystoscopies at regular follow-up assessments for post triple modality bladder preservation treatment in MIBC
39. OS02.3 Need for reclassifying treatment strategies for different subgroups of SHH medulloblastoma, paediatric and adult SHH-MB fail deferentially
40. P09.03 Bevacizumab in glioma: An experience from Tata Memorial Hospital
41. EO3 - Ga-68 PSMA PETCT response to androgen deprivation therapy in patients with prostate cancer
42. OT-05 * H3.3-K27M IS A NEGATIVE PROGNOSTIC MARKER IN THALAMIC PEDIATRIC GLIOMA
43. LG-03 * RADIATION THERAPY IS ASSOCIATED WITH INCREASED LATE MORTALITY IN LONG-TERM ADULT SURVIVORS OF CHILDHOOD LOW GRADE GLIOMA: A POPULATION BASED STUDY
44. LG-01 * BRAF MUTATION AND CDKN2A DELETION DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH-GRADE GLIOMA
45. PT-01 * THE IMPACT OF INITIAL RADIATION IN INFANTS AND THE RE-IRRADIATION OF RECURRENT DISEASE ON THE SURVIVAL OF EPENDYMOMA PATIENTS AT THE HOSPITAL FOR SICK CHILDREN, TORONTO
46. BI-21 * BRAF MUTATION AND CDKN2A DELETIONS DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH GRADE GLIOMA
47. The impact of initial radiation in infants and the re-irradiation of recurrent disease on the survival of ependymoma patients at The Hospital for Sick Children, Toronto
48. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
49. P140 - Adaptive radiotherapy for carcinoma of the urinary bladder: Long term outcomes with dose escalation.
50. Translation and pilot validation of Hindi, Marathi, and Bangla translation of quality of life EORTC module (QLQ-SH-22) for assessing sexual health-related quality of life.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.